This Pre-Solicitation opportunity from Department Of Defense was posted on May 12, 2026. The submission period has ended. Browse the details below for market research, or find similar active opportunities.

Top

Japanese Encephalitis Vaccine (JEV)

Closed

SPE2DP-26-R-0001Federal

Submission Closed05/29/2026, 03:59:00 AM UTC

Contract Overview

Solicitation details, issuing organization, response deadlines, documents, and interested companies for this government contract opportunity.

Active Opportunities Like This One

NAICS: 325414

New

SLED

Supply of INSTI HIV-1/HIV-2 Antibody Test KitsThe contract involves supplying FDA-approved INSTI HIV-1/HIV-2 Antibody Test kits to the Florida Department of Health. These kits are designed for rapid and early detection of HIV antibodies, which will aid in timely public health responses and interventions to control the spread of HIV. The procurement falls under the NAICS code 325414, which pertains to pharmaceutical preparation manufacturing. The solicitation for this subcontract was posted on June 16, 2026, with a response deadline set for July 10, 2026. Although specific location details for the office or place of performance are not provided, the contract is managed by the Florida Department of Health. The focus of this agreement is to support public health initiatives through the provision of essential diagnostic tools to improve HIV detection and subsequent care.

POSTED

DEADLINE

Supply of AmpliSeq Transcriptome ReagentsThe contract involves the supply of Ion AmpliSeq Transcriptome reagents alongside associated sequencing kits intended for transcriptomic analysis of blood samples collected from patients diagnosed with Alcohol Use Disorder as well as from control subjects. The materials supplied must be specifically compatible with low-input and degraded RNA samples, ensuring reliable results even when sample quality is compromised. This subcontract is to be performed in Rockville, with the National Institutes of Health under the Department of Health and Human Services serving as the issuing agency. The procurement is classified under NAICS code 325414, which pertains to pharmaceutical preparation manufacturing. The solicitation does not specify a set-aside type, and the response deadline is set for June 25, 2026, shortly after the contract posting date of June 16, 2026. The focus on specialized reagents for transcriptomic assays indicates the contract's role in supporting advanced biomedical research, particularly in understanding gene expression changes associated with Alcohol Use Disorder using state-of-the-art sequencing technologies.

National Institutes Of Health Olao

POSTED

DEADLINE

Ion AmpliSeq reagentsThe contract pertains to the procurement of Ion AmpliSeq reagents, with solicitation number 75N98026Q00637, issued by the National Institutes of Health under the Department of Health and Human Services. The notice, classified as a presolicitation, was posted on June 16, 2026, and specifies a response deadline of June 25, 2026. The procurement falls under the NAICS code 325414, indicating that it involves pharmaceuticals manufacturing. There is no set-aside designation applied to this contract, meaning it is open to all eligible bidders without reserved preference categories. The primary point of contact for this opportunity is David Shen, who can be reached via email. The contract office responsible for this solicitation is located in Bethesda, Maryland, with the performance site specified as Rockville, Maryland. The overall acquisition aims to secure Ion AmpliSeq reagents necessary for the agency’s research or operational needs, supporting activities related to health and biomedical research. Interested parties are directed to review detailed information and submit responses through the official federal contracting portal.

National Institutes Of Health Olao

POSTED

DEADLINE

Supply of Ligation Sequencing Kit XL V14The contract involves the procurement of six units of the Ligation Sequencing Kit XL V14 (SQK-LSK114-XL), intended for use in long-read sequencing workflows. These kits are essential for library preparation processes that support research into Alzheimer’s disease and Primary Progressive Aphasia (PCA), highlighting the contract's focus on advancing biomedical research through cutting-edge sequencing technology. Issued by the National Institutes of Health under the Department of Health and Human Services, this subcontract falls under the NAICS code 325414, which pertains to biological product manufacturing. The solicitation was posted on June 16, 2026, with responses due by June 26, 2026. The contract emphasizes timely procurement to support ongoing scientific investigations, although specific location and contact details are not disclosed.

National Institutes Of Health Olao

POSTED

DEADLINE

Supply of Columbia 5% Sheep Blood Agar PlatesThis contract involves the supply and delivery of 178 packets of Columbia 5% Sheep Blood Agar plates, which are used for microbiological culturing. The procurement is intended to support the US Embassy in Tbilisi, Georgia, and falls under the NAICS code 325414, which relates to biological product manufacturing. The contract is designated as a subcontract and was posted on June 16, 2026, with a response deadline set for July 6, 2026. The place of performance for this contract is Tbilisi, specifically with the postal code 0186. The Department of State is the overseeing agency administering the contract. While there is no specified solicitation number or set-aside type, the procurement clearly emphasizes timely delivery and the specialized nature of the product to ensure proper microbiological testing capabilities are maintained at the embassy location.

US Embassy Tbilisi

POSTED

2 days ago

DEADLINE

in 19 days

AI Contract Overview

The Defense Logistics Agency Troop Support is seeking suppliers for the Japanese Encephalitis Virus Vaccine in a purified, inactivated, single-dose prefilled syringe form, under solicitation number SPE2DP-26-R-0001. This firm-fixed price, indefinite delivery/indefinite quantity contract will have an 18-month base period and requires a minimum order quantity of 277,760 units, with an estimated quantity matching that minimum and a maximum of 394,240 units. The vaccine must meet the specifications outlined in MPID Number 5 dated July 23, 2024, and the successful contractor must hold FDA approval to sell the vaccine by the solicitation closing date. Delivery will be FOB destination to DLA Distribution Susquehanna in New Cumberland, Pennsylvania, with inspections and acceptance also occurring at the destination. Production lead time is set at 120 days following the issuance of each delivery order. The solicitation is issued under a sole-source authority per 10 U.S.C. § 3204(a)(1) and FAR 6.302-1, acknowledging that only one responsible source can fulfill the requirement. The acquisition will be conducted using procedures consistent with FAR Part 12. All interested and responsible sources can submit proposals for consideration, with solicitation documents and amendments available electronically on the DLA Internet Bid Board System (DIBBS). Potential offerors are encouraged to register on DIBBS to receive notifications and access full solicitation details. The contract is managed by DLA Troop Support’s Acquisition Management office based in Philadelphia, Pennsylvania, with designated contracting specialists available for contact.

General Info

DLA seeks FDA-approved Japanese Encephalitis vaccine supplier for 18-month, firm-fixed price contract.

Agency

Department Of Defense → DLA Troop Support

NAICS

325414 - Biological Product (except Diagnostic) Manufacturing View NAICS

Place of Performance

Philadelphia, PA, 19111, USA

Set-Aside

NONE

Documents

(2)

Medical Marking Standard No. 1D

PDF•specifications

MPID #5 Japanese Encephalitis Virus Vaccine Description and Requirements

PDF•mpid

AI Contract Breakdown

Uniform Contract Format

Timeline

PhaseClosed

PostedMay 12

Presolicitation

Response DeadlineMay 29

Deadline has passed

Submission Closed

05/29/2026, 03:59:00 AM UTC

Find active opportunities like this

Start your free trial to discover similar active contracts, track opportunities, and build proposals with AI assistance.

Organization & Contact Information

AgencyDepartment Of Defense → DLA Troop Support

Contacts1 person available

OfficePHILADELPHIA, PA, 19111, USA

Organization / Agency

Department Of Defense → DLA Troop Support

Office AddressPHILADELPHIA, PA, 19111, USA

Contacts

Jessica De La Hoz

contact@example.gov

+1 (555) 000-0000

Full Description

Japanese Encephalitis Virus Vaccine, Purified, Inactivated, Single-Dose Prefilled Syringe (JEV) - Synopsis

Solicitation: SPE2DP-26-R-0001

Item: Japanese Encephalitis Virus Vaccine, Purified, Inactivated, Single-Dose Prefilled Syringe (JEV)

NSN: 6505-01-607-7018

Description:

The Defense Logistics Agency Troop Support has a requirement for the supply of Japanese Encephalitis Virus Vaccine, Purified, Inactivated, Single-Dose Prefilled Syringe (JEV). JEV shall be made in accordance with MPID Number 5 dated 23 July 2024, which is attached to this notice.

The Solicitation will be issued under authority 10 U.S.C. § 3204(a)(1), implemented by FAR 6.302-1 (“Only one responsible source and no other supplies or services will satisfy agency requirements”).

The Government intends to use Part 12 for this acquisition – per FAR 10.002(d)(2).

The proposed contract will be a firm-fixed price, indefinite delivery, indefinite quantity type contract. The contract will consist of an eighteen (18) month base term. The minimum quantity is 277,760 each (EA). The estimated quantity is 277,760 each. The maximum quantity is 394,240 each.

Inspection/Acceptance at Destination

FOB Destination

Delivery Destination:

DODAAC: SV3100

DLA Distribution Susquehanna

U Avenue, Bldg. 89, Door 6

New Cumberland, PA 17070

Attn: Jim Earp

Production Lead Time is 120 days after issuance date of the delivery order (DD1155).

All responsible sources may submit a proposal and shall be considered by the Agency.

The successful contractor shall have FDA approval to sell JEV prior to the Solicitation’s closing date and time.

****************************************************************************

IMPORTANT NOTICES

Availability of solicitations, FAR 5.102(d) applies, as our office no longer issues solicitations or amendments in paper form. Offeror should register to receive notification of this solicitation or solicitation amendments. The solicitation will be posted on the DLA Internet Bid Board System (DIBBS) at https://www.dibbs.bsm.dla.mil/. Detailed system requirements and instructions for registration can be found on the DLA DIBBS Home Page accessed on https://www.dibbs.bsm.dla.mil/. Once the solicitation is posted, it will be available for viewing on DIBBS. From the DIBBS homepage, select "Solicitations" from the top bar to search for the solicitation. DIBBS Help can be accessed from the DIBBS homepage. Interested parties are further advised to set up automated notifications of solicitation changes through this website. Solicitation SPE2DP-23-R-0002 is expected to be issued on or around May 2024.

******************************************************************************
Contracting Office Address:

Defense Logistics Agency, Acquisition Management, DLA Troop Support - Medical, 700 Robbins Avenue, Philadelphia, PA, 19111-5092, UNITED STATES

Point of Contact(s):

Alec Deichman, Contracting Specialist, Phone: 445-737-5743 , Email: Alec.Deichman@dla.mil

Jessica De La Hoz, Contracting Officer, Phone: 445-737-3623, Email: Jessica.DeLaHoz@dla.mil